LarkaDrin Capsules and Novoeight recombinant
Determining the interaction of LarkaDrin Capsules and Novoeight recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: acetaminophen / dichloralphenazone / isometheptene mucate
Brand name: Nodolor
Synonyms: n.a.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- LarkaDrin Capsules-Novolin 70/30
- LarkaDrin Capsules-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- LarkaDrin Capsules-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- LarkaDrin Capsules-Novolin N
- LarkaDrin Capsules-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- LarkaDrin Capsules-Novolin N (Insulin NPH (Vials))
- Novoeight recombinant-Laronidase
- Novoeight recombinant-Laronidase Intravenous
- Novoeight recombinant-Larotrectinib
- Novoeight recombinant-Larotrectinib Capsules
- Novoeight recombinant-Larotrectinib Oral Solution
- Novoeight recombinant-Larotrectinib Sulfate